» Articles » PMID: 37987966

Comparative Analysis of Information Provided in German Adverse Drug Reaction Reports Sent by Physicians, Pharmacists and Consumers

Overview
Journal Drug Saf
Specialties Pharmacology
Toxicology
Date 2023 Nov 21
PMID 37987966
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Adverse drug reactions (ADRs) can be reported by Health Care Professionals (HCPs; e.g., physicians, pharmacists) and non-Health Care Professionals (non-HCPs; e.g., consumers). Previous studies investigating differences between reports from HCPs and non-HCPs rarely considered the completeness of information provided. In addition, they mostly did not distinguish between physicians and pharmacists or were performed years ago. The aim of our study was to analyse and compare the completeness of information provided in reports from physicians, pharmacists and consumers from Germany in a more recent dataset.

Materials And Methods: We analysed all spontaneous reports from Germany received between 2018 and 2021 in the ADR database EudraVigilance exclusively reported by physicians (n = 69,976), pharmacists (n = 42,396) or consumers (n = 121,144). Demographical parameters of the patients were analysed descriptively. Completeness of reports was evaluated applying an established score (vigiGrade). Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using logistic regression analysis in order to identify report, patient, drug or ADR-specific information provided more often in reports from physicians, pharmacists or consumers.

Results: Within the study period the number of reports per year by physicians and pharmacists decreased steadily, while an opposite trend was observed for consumer reports. The proportion of female patients was higher in reports from pharmacists (64.4%) and consumers (64.8%) compared to those from physicians (55.3%). On average, patients in reports from pharmacists (58.7) were older compared to those from physicians (53.5) and consumers (52.6). As an example for the presence of specific information, the time to onset of the ADR could be calculated more often in consumer compared to physician (OR 1.9 [1.8-1.9]) and pharmacist reports (OR 1.7 [1.6-1.7]). In contrast, pharmacist (OR 0.5 [0.4-0.5]) and consumer (OR 0.5 [0.5-0.5]) reports included the indication of the suspected drug less often than physician reports. Physician reports on average (mean = 0.5) were slightly more complete according to the vigiGrade score compared to reports from consumers (mean = 0.4) and pharmacists (mean = 0.4).

Conclusion: The ADR reports from consumers were comparable with regard to the completeness score with those from physicians and pharmacists underlining their value. Differences in completeness of specific information between the reporter types were found, suggesting that a common reporting of interactions between the three reporters may further improve the completeness of ADR reports. Furthermore, stratified analysis of ADR reports per reporter type may be helpful for certain objectives in scientific research.

Citing Articles

[Drug safety and mandatory reporting].

Behles C, Hoffmann R, Lex D Schmerz. 2025; .

PMID: 39847136 DOI: 10.1007/s00482-024-00857-3.


Analyses of Adverse Drug Reactions to Fluoroquinolones in Spontaneous Reports Before and After the Referral and in Clinical Routine Cases.

Dubrall D, Wicherski J, Below M, Gortzen-Patin J, Schmid M, Zenker S Drugs R D. 2025; .

PMID: 39833604 DOI: 10.1007/s40268-024-00499-x.


Safety assessment of deutetrabenazine: real-world adverse event analysis from the FAERS database.

Shu Y, Wang Y, Liu J, Hu L, Tong S, Wu G Front Pharmacol. 2025; 15:1498215.

PMID: 39764469 PMC: 11701039. DOI: 10.3389/fphar.2024.1498215.


Pharmacovigilance Strategies to Address Resistance to Antibiotics and Inappropriate Use-A Narrative Review.

Sandes V, Figueras A, Lima E Antibiotics (Basel). 2024; 13(5).

PMID: 38786184 PMC: 11117530. DOI: 10.3390/antibiotics13050457.

References
1.
Dubrall D, Just K, Schmid M, Stingl J, Sachs B . Adverse drug reactions in older adults: a retrospective comparative analysis of spontaneous reports to the German Federal Institute for Drugs and Medical Devices. BMC Pharmacol Toxicol. 2020; 21(1):25. PMC: 7092423. DOI: 10.1186/s40360-020-0392-9. View

2.
Inacio P, Cavaco A, Airaksinen M . The value of patient reporting to the pharmacovigilance system: a systematic review. Br J Clin Pharmacol. 2016; 83(2):227-246. PMC: 5237689. DOI: 10.1111/bcp.13098. View

3.
Kuhn M, Letunic I, Jensen L, Bork P . The SIDER database of drugs and side effects. Nucleic Acids Res. 2015; 44(D1):D1075-9. PMC: 4702794. DOI: 10.1093/nar/gkv1075. View

4.
Sandberg A, Ehlers P, Torvinen S, Sandberg H, Siven M . Regulation Awareness and Experience of Additional Monitoring among Healthcare Professionals in Finland. Healthcare (Basel). 2021; 9(11). PMC: 8622083. DOI: 10.3390/healthcare9111540. View

5.
Thiessard F, Roux E, Miremont-Salame G, Fourrier-Reglat A, Haramburu F, Tubert-Bitter P . Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001). Drug Saf. 2005; 28(8):731-40. DOI: 10.2165/00002018-200528080-00007. View